{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:08:18Z","timestamp":1723939698769},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Nonvalvular atrial fibrillation (AF) is a common rhythm disorder of middle-aged to older adults that can cause ischemic strokes and systemic embolism. Stroke prevention is a crucial aspect of management, considering the increasing AF population and the associated morbidity and mortality. The left atrial appendage (LAA) has been identified as a predominant source of AF-associated thrombus and stroke, with at least 90% of the thrombi originating from this anatomical structure. Lifelong use of oral anticoagulants reduces the risk of these ischemic events but increases the risk of major and clinically relevant hemorrhages. In addition, these medications also require strict compliance for efficacy and have high failure rates in higher-risk patients. LAA occlusion (LAAO) has emerged as an alternative strategy for stroke prevention with encompassing various percutaneous and surgical techniques. Randomized controlled trials evaluating this intervention have shown promising results in stroke reduction replacing anticoagulation therapy. In this review, we aim to provide a comprehensive overview on the anatomy of the LAA and its role in thrombus formation, the emergence of various LAAO techniques and devices, and provide evidence on the role of LAAO in the reduction of stroke risk among patients with nonvalvular AF.<\/jats:p>","DOI":"10.1097\/crd.0000000000000757","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T13:16:28Z","timestamp":1722345388000},"update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Left Atrial Appendage Occlusion as a Strategy for Reducing Stroke Risk in Nonvalvular Atrial Fibrillation"],"prefix":"10.1097","author":[{"given":"Errol","family":"Moras","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kruti","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyas","family":"Yakkali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jacobi Medical Center\/Albert Einstein College of Medicine, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"R1-20240817","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"R2-20240817","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"R3-20240817","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacep.2018.02.021","article-title":"Burden of atrial fibrillation\u2013associated ischemic stroke in the United States.","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"R4-20240817","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure.","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R5-20240817","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.mayocp.2018.09.025","article-title":"Left atrial appendage occlusion for the unmet clinical needs of stroke prevention in nonvalvular atrial fibrillation.","volume":"94","author":"Holmes","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R6-20240817","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.jacc.2018.04.013","article-title":"Stroke prevention in nonvalvular atrial fibrillation: a stakeholder perspective.","volume":"71","author":"Alkhouli","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R7-20240817","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R8-20240817","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jcmg.2015.02.002","article-title":"Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography.","volume":"8","author":"Wunderlich","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"R9-20240817","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2012.04.032","article-title":"Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study.","volume":"60","author":"Di Biase","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R10-20240817","doi-asserted-by":"crossref","first-page":"e022274","DOI":"10.1161\/JAHA.121.022274","article-title":"Left atrial appendage occlusion for stroke prevention in nonvalvular atrial fibrillation.","volume":"10","author":"Collado","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R11-20240817","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/hrt.82.5.547","article-title":"Left atrial appendage: structure, function, and role in thromboembolism.","volume":"82","author":"Al-Saady","year":"1999","journal-title":"Heart"},{"key":"R12-20240817","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited.","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"R13-20240817","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"R14-20240817","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2013.08.1631","article-title":"Left atrial appendage occlusion: opportunities and challenges.","volume":"63","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R15-20240817","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jacc.2008.03.067","article-title":"Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography.","volume":"52","author":"Kanderian","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R16-20240817","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ahj.2004.09.054","article-title":"Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.","volume":"150","author":"Healey","year":"2005","journal-title":"Am Heart J"},{"key":"R17-20240817","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jtcvs.2011.07.052","article-title":"Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.","volume":"142","author":"Ailawadi","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R20-20240817","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke.","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"R21-20240817","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion \u2013 an update.","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"R22-20240817","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/01.CIR.0000015698.54752.6D","article-title":"Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation.","volume":"105","author":"Sievert","year":"2002","journal-title":"Circulation"},{"key":"R23-20240817","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4244\/EIJV6I2A35","article-title":"PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.","volume":"6","author":"Bayard","year":"2010","journal-title":"EuroIntervention"},{"key":"R24-20240817","doi-asserted-by":"crossref","first-page":"e026295","DOI":"10.1161\/JAHA.122.026295","article-title":"Two-year outcomes with a next-generation left atrial appendage device: final results of the PINNACLE FLX trial.","volume":"12","author":"Doshi","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"R25-20240817","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial.","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"R26-20240817","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial.","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"R27-20240817","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcm.2018.08.008","article-title":"An overview of current and emerging devices for percutaneous left atrial appendage closure.","volume":"29","author":"Chow","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"R28-20240817","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jcin.2018.01.275","article-title":"Minimalistic approach to left atrial appendage occlusion using the LAmbre device.","volume":"11","author":"So","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R29-20240817","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4330\/wjc.v11.i2.57","article-title":"Percutaneous devices for left atrial appendage occlusion: a contemporary review.","volume":"11","author":"Pacha","year":"2019","journal-title":"World J Cardiol"},{"key":"R30-20240817","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jacc.2012.06.046","article-title":"Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience.","volume":"62","author":"Bartus","year":"2013","journal-title":"J Am Coll Cardiol"},{"article-title":"Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques.","author":"Bergmann","key":"R31-20240817","doi-asserted-by":"crossref","DOI":"10.4244\/EIJV10I4A86"},{"key":"R32-20240817","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/joic.12541","article-title":"Left atrial appendage closure with the Ultraseal device: initial experience and mid-term follow-up.","volume":"31","author":"Pagnotta","year":"2018","journal-title":"J Interv Cardiol"},{"key":"R33-20240817","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jcin.2018.05.023","article-title":"Percutaneous left atrial appendage closure with the ultraseal device: insights from the initial multicenter experience.","volume":"11","author":"Asmarats","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R34-20240817","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jacc.2019.09.064","article-title":"Long-term safety and efficacy in continued access left atrial appendage closure registries.","volume":"74","author":"Holmes","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R35-20240817","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure.","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"R36-20240817","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation.","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R37-20240817","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"R38-20240817","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes.","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"key":"R39-20240817","doi-asserted-by":"crossref","first-page":"100136","DOI":"10.1016\/j.jacadv.2022.100136","article-title":"Left atrial appendage occlusion.","volume":"1","author":"Alkhouli","year":"2022","journal-title":"JACC Adv"},{"key":"R40-20240817","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion.","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R41-20240817","doi-asserted-by":"crossref","first-page":"e005997","DOI":"10.1161\/CIRCINTERVENTIONS.117.005997","article-title":"Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy.","volume":"11","author":"Pracon","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"R42-20240817","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1002\/ccd.26903","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet.","volume":"90","author":"Lempereur","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"R43-20240817","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","article-title":"The clinical impact of incomplete left atrial appendage closure with the watchman device in patients with atrial fibrillation.","volume":"59","author":"Viles -Gonzalez Juan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R44-20240817","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"R45-20240817","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ccd.25891","article-title":"Embolization of left atrial appendage closure devices: a systematic review of cases reported with the watchman device and the amplatzer cardiac plug.","volume":"86","author":"Aminian","year":"2015","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T17:02:57Z","timestamp":1723914177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":43,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000757","relation":{},"ISSN":["1061-5377"],"issn-type":[{"type":"print","value":"1061-5377"}],"subject":[],"published":{"date-parts":[[2024,7,30]]}}}